Discrepancies of SARS-CoV-2 testing results among patients with total laryngectomy
- PMID: 34853865
- PMCID: PMC8636284
- DOI: 10.1007/s00405-021-07203-8
Discrepancies of SARS-CoV-2 testing results among patients with total laryngectomy
Abstract
Purpose: Prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is obtained with nasopharyngeal swabs. By the way, there is no consensus regarding sampling in totally laryngectomized subjects (who thus breathe directly by the tracheostomy and, theoretically, may be infected in the trachea). The aim of this study is to evaluate possible differences between swab results in the trachea and in the nasopharynx of this category of patients.
Methods: A retrospective chart review was performed in April 2021 among patients who previously had been operated on for total laryngectomy and who underwent swabs for SARS-CoV-2 research in 3 health-care centers in Northern-Eastern Italy. Data regarding the site of swabbing (trachea or nasopharynx) were analyzed. A comprehensive review of the literature regarding the same topic was then performed.
Results: A total of 25 totally laryngectomized subjects underwent swabs. Among them, 5 tested positive in the trachea (1) and in the nasopharynx (4). According to the literature review, 4 more subjects tested positive in the trachea (1) and in the nasopharynx (3). Data were overall divergent and no statistically significant correlations emerged between results of the tests performed in the two sites.
Conclusion: Due to these discrepancies, both tracheal and nasopharyngeal swabs are recommended in these kinds of patients, to obtain a reliable test and to avoid false negatives.
Keywords: COVID-19; Nasopharyngeal swab; SARS-CoV-2; Total laryngectomy; Tracheal swab.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
The authors have no conflict of interest, funding or financial relationships. An informed consent has been obtained for any procedure involving the patients described in this article. The manuscript has not been submitted to more than one journal for simultaneous consideration. The manuscript has not been published previously (party or in full). All of the authors have participated in the planning, writing or revising the manuscript.
References
-
- Centers for Disease Control and Prevention. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specim.... Accessed in 31 May 2021
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous